Celestica Inc. surpassed Q1 estimates and raised 2025 guidance. AI switch demand fuels growth, but margin risks persist.

Kimberly-Clark (NYSE:KMB) has attracted attention with mergers and acquisition rumors concerning its international tissue ...

Leap Therapeutics, Inc. , a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today announced it will present preclinical data of FL-501 in a poster presentation ...

Apple AAPL is set to release its fiscal second-quarter earnings report on May 1. Here’s Morningstar’s take on what to look ...

We recently published a list of the 11 Most Promising Small-Cap Stocks According to Analysts. In this article, we are going ...

Conference/Scientific publicationPentixapharm to Present First-in-Class Glycan-Dependent CD24 Antibody GT-008 for Solid Tumors at AACR 2025 25.04.2025 / 15:39 CET/CESTThe issuer is solely responsible ...

The firm’s 2021 spinoff of Technip Energies (representing the firm’s onshore E&C business) transformed TechnipFMC into a pure-play technology and service provider for the offshore market. TechnipFMC ...

The consensus price target for Colgate-Palmolive Company (NYSE:CL) has been adjusted downwards, from $102.25 a year ago to ...

Subscribe to TheStreet's free daily newsletter There's a long-running joke that it's impossible to walk into Target without ...

Chris Albi, group VP of operations at King Soopers & City Markets, will step into Kelley’s now-former role as president of ...

Atlassian, HubSpot, Salesforce, and Microsoft limits its vertical expansion potential. Read more about MNDY stock here.

First preclinical data of novel targeted Radio-DARPin against mesothelin (MSLN), in co-development with Orano Med "Our presentations at AACR highlight the breadth of Molecular Partners' DARPin ...